medigraphic.com
ISSN 1527-3172 (Digital)

2022, Número 1

<< Anterior Siguiente >>

MEDICC Review 2022; 24 (1)


Percutaneous coronary intervention versus myocardial revascularization surgery in multivessel coronary artery disease: Four-year followup

Naranjo-Domínguez A, Aroche-Aportela R, Hernández-Navas M, Aldama-Pérez LI, García-Hernández RA, Valdés-Martín A

Idioma: Ingles.
Referencias bibliográficas: 12
Paginas: 40-43
Archivo PDF: 173.26 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. National Health Statistics and Medical RecordsDivision (CU). Anuario Estadístico de Salud 2020[Internet]. Havana: Ministry of Public Health (CU); 2021 Apr [cited 2021 Sep 17]. 206 p. Available at:https://fi les.sld.cu/bvscuba/fi les/2021/08/Anuario-Estadistico-Espa%c3%b1ol-2020-Defi nitivo.pdf.Spanish.

  2. Lee PH, Park H, Lee JS, Lee SW, Lee CW.Meta-analysis comparing the risk of myocardialinfarction following coronary artery bypassgrafting versus percutaneous coronary interventionin patients with multivessel or left maincoronary artery disease. Am J Cardiol [Internet].2019 Sep 15 [cited 2021 Jul 3];124(6):842–50.Available at: https://www.ajconline.org/article/S0002-9149(19)30709-X/fulltext

  3. Thygesen K, Alpert JS, Jaff e AS, ChaitmanBR, Bax JJ, Morrow DA, et al. Fourth universaldefi nition of myocardial infarction (2018).Eur Heart J [Internet]. 2019 Jan 14 [cited 2021Jul 6];40(3):237–69. Available at: https://doi.org/10.1093/eurheartj/ehy462

  4. Naranjo-Domínguez N, Aroche Aportela R,Hernández Navas M, Aldama L, Valdés MartínAV, Vitón Castillo AA. Utilidad pronóstica del puntajeSYNTAX en pacientes con enfermedad coronariamultiarterial. Seguimiento de 4 años. RevCubana Cardiol Cir Cardiovasc [Internet]. 2021Jul 1 [cited 2021 Jul 6];27(3):1234. Availableat: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1234. Spanish.

  5. Serruys PW, Morice M-C, Kappetein AP, ColomboA, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-arterybypass grafting for severe coronary artery disease.N Engl J Med [Internet]. 2009 Mar 5 [cited2021 Apr 15];360(10):961–72. Available at:https://doi.org/10.1056/NEJMoa0804626

  6. Shah KS, Xu H, Matsouaka RA, Bhatt DL,Heidenreich PA, Hernández AF, et al. Heartfailure with preserved, borderline, and reducedejection fraction: 5-year outcomes. J Am CollCardiol [Internet]. 2017 Nov 14–21 [cited 2021Jul 6];70(20):2476–86. Available at: https://www.sciencedirect.com/science/article/pii/S0735109717397619

  7. Hlatky MA, Boothroyd DB, Bravata DM, BoersmaE, Booth J, Brooks MM, et al. Coronary arterybypass surgery compared with percutaneouscoronary interventions for multivessel disease:a collaborative analysis of individual patient datafrom ten randomised trials. Lancet [Internet].2009 Apr 6 [cited 2021 Apr 16];373(9670):1190–7. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60552-3/

  8. Mohr FW, Morice M-C, Kappetein AP, FeldmanTE, Ståhle E, Colombo A, et al. Coronary arterybypass graft surgery versus percutaneous coronaryintervention in patients with three-vesseldisease and left main coronary disease: 5-yearfollowup of the randomised, clinical SYNTAXtrial. Lancet [Internet]. 2013 Feb 23–Mar 1 [cited2021 Apr 15];381(9867):629–38. Available at:https://www.sciencedirect.com/science/article/pii/S0140673613601415

  9. Naranjo-Domínguez A, Aroche Aportela R,Hernández M, Obregón A, Aldama L. Variabilidadinterobservador del Score SYNTAX enpacientes con diagnóstico de enfermedad arterialcoronaria multivaso. Rev Cubana Cardiol CirCardiovasc [Internet]. 2018 Jun 4 [cited 2021 Jul6];24(2):141–54. Available at: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/761. Spanish.

  10. Thuijs DJFM, Kappetein AP, Serruys PW, MohrF-W, Morice M-C, Mack MJ, et al. Percutaneouscoronary intervention versus coronary arterybypass grafting in patients with three-vessel orleft main coronary artery disease: 10-year followupof the multicentre randomised controlledSYNTAX trial. Lancet [Internet]. 2019 Oct 12[cited 2021 Jul 6];394(10206):1325–34. Availableat: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31997-X/fulltext

  11. Aroche Aportela R, Navarro Rodríguez AY, GarcíaOrcid RA, Hernández Nava M, ObregónSantos AG, Aldama Pérez L. Efectividad de laintervención coronaria percutánea con stent liberadorde paclitaxel frente a stent convencional.Rev Cubana Cardiol Cir Cardiovasc [Internet].2020 Jul 1 [cited 2021 Jul 3];26(3):1011. Availableat: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1011. Spanish.

  12. López Ramírez M, Nafeh Abi-Resk M, LeyvaQuert A, Gutiérrez Lípez A, Tamargo BarbeitoTO, López Ramírez D, et al. Intervencionismocoronario frente a cirugía de revascularizaciónmiocárdica en pacientes con enfermedad multivaso.Rev Cubana Cardiol Cir Cardiovasc [Internet].2017 Oct 27 [cited 2021 Jul 4];23(3):361–70.Available at: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/700. Spanish.




2020     |     www.medigraphic.com